蕈样真菌病
布仑妥昔单抗维多汀
皮肤病科
医学
内科学
肿瘤科
霍奇金淋巴瘤
淋巴瘤
作者
Mariel James,Mano Nakamura,Sean Whittaker,Stephen Morris
摘要
UK guidelines currently endorse only one course of brentuximab vedotin as second-line treatment for CD30+ CTCL. We demonstrate that re-treatment can be safe, tolerable and highly efficacious in selected patients.
科研通智能强力驱动
Strongly Powered by AbleSci AI